Replies to post #8753 on ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Big Bambino, I agree, in the meantime the 2019 launches into at least $1.975 billion combined market should drive PPS north handsomely. Then next year Q1, possibly sooner, filing of Corti SNDA should give us another pop in PPS. We could then go into hyper growth if we get Libigel dusted off and Corti approval in 2020.

Should be a good run with or without Libigel.